메뉴 건너뛰기




Volumn 16, Issue 12, 2007, Pages 1867-1878

Discontinued drugs in 2006: Anti-infectives

Author keywords

Anti infectives; Coronavirus; Discontinued drugs; HIV; Pseudomonas aeruginosa; Respiratory syncytial virus; SARS virus; Severe acute respiratory syndrome

Indexed keywords

4' AZIDOCYTIDINE; A 33903; A 60444; AERUGEN; ALPHA GLYCINAMIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; BISMUTH 201; BMS 2; BMS 605339; DIDANOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELVUCITABINE; GR 270773; HEPATITIS C VIRUS PROTEASE INHIBITOR; MONOCLONAL ANTIBODY; PLACEBO; PROTEIN INHIBITOR; PROTEINASE INHIBITOR; PSEUDOMONAS VACCINE; RIBAVIRIN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; SINOVAC; UNCLASSIFIED DRUG;

EID: 39549111525     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.16.12.1867     Document Type: Article
Times cited : (2)

References (6)
  • 1
    • 11244332034 scopus 로고    scopus 로고
    • Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide
    • ANDERSSON E, HORAL P, JEJCIC A et al.: Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide. Antimicrob. Agents Chemother. (2005) 49:40-44.
    • (2005) Antimicrob. Agents Chemother , vol.49 , pp. 40-44
    • ANDERSSON, E.1    HORAL, P.2    JEJCIC, A.3
  • 2
    • 35948949782 scopus 로고    scopus 로고
    • RSV604, a novel inhibitor of respiratory syncytial virus replication
    • CHAPMAN J, ABBOTT E, ALBER DG et al.: RSV604, a novel inhibitor of respiratory syncytial virus replication. Antimicrob. Agents Chemother. (2007) 51:3346-3353.
    • (2007) Antimicrob. Agents Chemother , vol.51 , pp. 3346-3353
    • CHAPMAN, J.1    ABBOTT, E.2    ALBER, D.G.3
  • 3
    • 0036412170 scopus 로고    scopus 로고
    • Is angiotensin I-converting enzyme a "master" disease gene?
    • MOSKOWITZ DW: Is angiotensin I-converting enzyme a "master" disease gene? Diabetes Technol. Ther. (2002) 4:683-711.
    • (2002) Diabetes Technol. Ther , vol.4 , pp. 683-711
    • MOSKOWITZ, D.W.1
  • 4
    • 33745112513 scopus 로고    scopus 로고
    • Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis
    • ZUERCHER AW, HORN MP, QUE JU et al.: Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol. Med. Microbiol. (2006) 47:302-308.
    • (2006) FEMS Immunol. Med. Microbiol , vol.47 , pp. 302-308
    • ZUERCHER, A.W.1    HORN, M.P.2    QUE, J.U.3
  • 5
    • 84864574910 scopus 로고    scopus 로고
    • New antimicrobial agents approved by the US food and drug administration in 2006 and new indications for previously approved agents
    • ANONYMOUS
    • ANONYMOUS: New antimicrobial agents approved by the US food and drug administration in 2006 and new indications for previously approved agents. Antimicrob. Agents Chemother. (2007) 51:2649.
    • (2007) Antimicrob. Agents Chemother , vol.51 , pp. 2649
  • 6
    • 21744454117 scopus 로고    scopus 로고
    • Investigation of glycine α-ketoamide HCV NS3 protease inhibitors: Effect of carboxylic acid isosteres
    • HAN W, JIANG Y, HU Z, WASSERMAN ZR, DECICCO CP: Investigation of glycine α-ketoamide HCV NS3 protease inhibitors: effect of carboxylic acid isosteres. Bioorg. Med. Chem. Lett. (2005) 15(15):3487-3490.
    • (2005) Bioorg. Med. Chem. Lett , vol.15 , Issue.15 , pp. 3487-3490
    • HAN, W.1    JIANG, Y.2    HU, Z.3    WASSERMAN, Z.R.4    DECICCO, C.P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.